Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
symphoglobulin-d (1 trial)
Purpura (Phase 2)
Purpura, Thrombocytopenic (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Trials (1 total)
Trial APIs (1 total)